Sign up to save your podcasts
Or
Share Pfizer, Inc. (PFE), 2025 Q1 earnings digest
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pfizer, Inc. (PFE), 2025 Q1 earnings digest
$PFE reports Q1 2025 earnings: EPS of $0.92 beats expectations, while revenue of $13.72B reflects a 7.82% decline year-over-year, missing estimates. The decrease is attributed to lower Paxlovid sales and the impact of Medicare Part D redesign. 🩺💰
View all episodes
By ValueVerge$PFE reports Q1 2025 earnings: EPS of $0.92 beats expectations, while revenue of $13.72B reflects a 7.82% decline year-over-year, missing estimates. The decrease is attributed to lower Paxlovid sales and the impact of Medicare Part D redesign. 🩺💰